Iradimed IRMD
NASDAQ IRMD
$83.41 -0.99 (-1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Iradimed (IRMD) Debt Ratio (2013)

Iradimed's (IRMD) quarterly Debt Ratio came in at 0.0 in Q4 2013.

Analysis

Iradimed (IRMD) Debt Ratio (2013) Analysis & Trends

Iradimed (IRMD) has reported Debt Ratio for 1 consecutive years, with 0.0 the latest figure, recorded in Q4 2013.

  • On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.0 in Q4 2013; TTM through Dec 2013 was 0.0, a N/A change from a year earlier, with the FY2013 full-year figure at 0.0, changed N/A from the prior year.
  • Debt Ratio was 0.0 for Q4 2013 at Iradimed.
  • Over five years, Debt Ratio peaked at 0.0 in Q4 2013 and troughed at 0.0 in Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 0.30
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 0.30
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 0.31
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 0.28
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 0.04
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 0.13
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 0.20
10 Iradimed 1.07 Bn 1.01 Bn 15.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 0.00